Acquire the license to the best health content in the world
Contact Us

Clinical Trials Update: Feb. 11, 2009

Vaccines Schizophrenia and Schizoaffective Disorders Multiple Sclerosis

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Vaccines

If you are at least 65, have not received a tetanus booster shot in the last five years, and have never received the Tdap vaccine, you may qualify for this study.

The research site is in Mount Pleasant, S.C.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=372.

-----

Schizophrenia and Schizoaffective Disorders

If you are aged 18 to 55, have been diagnosed with schizophrenia, and are currently being treated with a stable dose of Seroquel, Zyprexa, Risperdal, or Abilify, you may qualify for this study.

The research site is in Cherry Hill, N.J.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=135.

-----

Multiple Sclerosis

If you are aged 18 to 55, have a confirmed diagnosis of relapsing/remitting multiple sclerosis, have had at least one relapse in the last 12 months or two relapses in the last 24 months, and have never been treated with interferon medications such as Avonex, Betaseron, or Rebif, you may qualify for this study.

The research site is in Cedarhurst, N.Y.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=102.

-----

Copyright 2009 CenterWatch. All rights reserved.

Consumer News